ID   YN
AC   CVCL_Y579
DR   Wikidata; Q54995453
RX   CelloPub=CLPUB00569;
RX   PubMed=3541491;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Population: Japanese.
CC   Doubling time: 36.2 hours (Note=At 8th passage), 21.6 hours (Note=At 47th passage) (PubMed=3541491).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
RX   CelloPub=CLPUB00569;
RA   Dickman P.S., Tsokos M.G., Triche T.J.;
RT   "Biology of rhabdomyosarcoma: cell culture, xenografts, and animal
RT   models.";
RL   (In book chapter) Rhabdomyosarcoma and related tumors in children and adolescents; Maurer H.M., Ruymann F.B., Pochedly C.E. (eds.); pp.49-88; CRC Press; Boca Raton; USA (1991).
//
RX   PubMed=3541491; DOI=10.1111/j.1440-1827.1986.tb02821.x;
RA   Motoyama T., Watanabe H., Yamamoto T.;
RT   "Embryonal rhabdomyosarcoma in nude mice and in vitro.";
RL   Acta Pathol. Jpn. 36:1495-1505(1986).
//
RX   PubMed=23665679; DOI=10.1038/onc.2013.129;
RA   Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.;
RT   "Proof-of-concept rare cancers in drug development: the case for
RT   rhabdomyosarcoma.";
RL   Oncogene 33:1877-1889(2014).
//
RX   PubMed=23882450; DOI=10.3389/fonc.2013.00183; PMCID=PMC3713458;
RA   Hinson A.R.P., Jones R., Crose L.E.S., Belyea B.C., Barr F.G.,
RA   Linardic C.M.;
RT   "Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research:
RT   utility and pitfalls.";
RL   Front. Oncol. 3:183.1-183.12(2013).
//